UNSPSC 51111748: Ladirubicin

This classification denotes an anthracycline antibiotic with the molecular formula C29H31NO11S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U395ERO49H. The term LADIRUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 1, 2001, list 45. ). Most nations schedule ladirubicin under HS 29419000 and SITC 54139. As of Q4 2014, LADIRUBICIN remains the US FDA Preferred Term for this commodity. Ladirubicin bears US NLM identifiers UMLS ID C2827222 and NCI Concept Code C83861.

SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N6CC6)OS(=O)(=O)C.

UNSPSC 51111748 Ladirubicin, a Commodity code, shows limited recent state and local procurement activity aligned with its nominal scope. The code nominally covers a specific chemotherapy agent, but the recent opportunities posted under it diverge substantially from that product category—instead naming antibiotic tablets, naloxone, and drug deactivation systems. State and local procurement offices do source specialized pharmaceuticals through piggyback and cooperative purchasing arrangements, but the opportunities tagged to this code reflect broader pharmaceutical and medical supply procurement rather than ladirubicin specifically. Illinois Department of Public Health and Seminole County, Florida appear in recent activity, both using competitive bidding processes (Invitation for Bid and IFB notices) to procure medical supplies with multi-year contract terms and quarterly or ongoing delivery schedules.

Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, covering Doxycycline Hyclate and Ciprofloxacin Hydrochloride over a 12-month initial term with two renewal options. Seminole County, Florida issued IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida. The code shows activity concentrated in the Southeast and Midwest, though the mismatch between the code's advertised product (ladirubicin) and the actual procurements posted (antibiotics, naloxone, deactivation equipment) suggests either tagging errors in the source data or that this code sees limited genuine ladirubicin procurement at the state and local level. Firms pursuing pharmaceutical supply contracts should verify code alignment directly with issuing bodies rather than rely on UNSPSC taxonomy alone.